Citation map · Study

Need for Multicriteria Evaluation of Generic Drug Policies

14 references·0 citing·43 second hop

this work references cited by second hop

References

2007Prescription drug cost sharing: associations with medication and medical utilization and spending and health.875 cited
2012Economic and Technological Drivers of Generic Sterile Injectable Drug Shortages183 cited
2014Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States168 cited
2003The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs154 cited
2010Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications153 cited
2010Generic and therapeutic substitutions in the UK: are they a good thing?149 cited
2012Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000–2010144 cited
2012The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview115 cited
2008Pharmaceutical pricing policies in a global market107 cited
2003Report of the American Society of Transplantation Conference on Immunosuppressive Drugs and the Use of Generic Immunosuppressants104 cited
2011Does the Market Share of Generic Medicines Influence the Price Level?85 cited
2010Switching from Brand‐Name to Generic Psychotropic Medications: A Literature Review84 cited
2008Price control as a strategy for pharmaceutical cost containment—What has been achieved in Norway in the period 1994–2004?

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Cited by

No citing works inside the corpus for this window.